Regulatory NewsBREAK July 2, 2024 August 29, 2023: CMS Announces First Selected Drugs for Medicare Price Negotiation
Regulatory NewsBREAK July 2, 2024 August 30, 2023: FDA Issued Guidance on Real-World Data and Real-World Evidence to Support Regulatory Decision-Making for Drug and Biological Products
Regulatory NewsBREAK July 2, 2024 September 14, 2023: FDA Issues Updated Final Guidance on the Breakthrough Devices Program
Regulatory NewsBREAK July 2, 2024 HHS and DEA Issue Second Temporary Extension of COVID-19 Telemedicine Flexibilities for Controlled Medications
Regulatory NewsBREAK July 2, 2024 CMS Issues Guidance on Medicare Part D Manufacturer Discount Program Medicare Part D
Regulatory NewsBREAK July 2, 2024 CMS Issues Revised Program Guidance on the Medicare Inflation Rebate Program
Regulatory NewsBREAK July 2, 2024 ONC Issues Final Rule on Health Data, Technology, and Interoperability